LORNOXICAM

LORNOXICAM: Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) that is commonly used to relieve pain and inflammation associated with various conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute gout. It is available in both oral and injectable forms.

The exact mechanism of action of lornoxicam is not fully understood, but it is believed to work by inhibiting the production of prostaglandins, which are responsible for inflammation and pain. By inhibiting the enzyme cyclooxygenase (COX), lornoxicam reduces the synthesis of prostaglandins, thereby reducing pain, inflammation, and swelling.

The typical dose of lornoxicam varies depending on the condition being treated, the severity of symptoms, and the patient’s age and overall health. In general, the recommended oral dose for adults is 8-16 mg/day, divided into 2-3 doses. For injectable lornoxicam, the recommended dose is 8-16 mg/day, given as a single injection. The duration of treatment should be as short as possible, usually not exceeding 7-14 days.

While lornoxicam is generally well tolerated, it can cause some side effects. Common side effects include indigestion, nausea, vomiting, diarrhea, abdominal pain, dizziness, headache, and skin rash. Less frequently, it may cause more serious side effects such as gastrointestinal bleeding, ulceration, kidney problems, and hypersensitivity reactions. It is important to use lornoxicam under medical supervision and to report any unusual or severe side effects to a healthcare professional.

Lornoxicam should not be used in individuals who have a known hypersensitivity to NSAIDs, aspirin, or other COX inhibitors. It is not recommended for use in pregnant women, especially during the third trimester, as it may harm the unborn baby. Additionally, lornoxicam may interact with certain medications, so it is important to inform a healthcare professional about all current medications before starting treatment with lornoxicam.